Gentueri Inc. Receives FDA Facility Registration and Device Listing

December 14, 2020

Gentueri Inc., a crisis innovator leading in the fight against COVID-19, received confirmation of its FDA Facility Registration and Device Listing.

Gentueri Inc, founded by Randy Nagy in 2012, specializes in advancing the collection, preservation, and processing of biological samples with innovative devices and kits.

Historically, Gentueri has provided DNA collection kits to the forensic market, launching some of the most innovative DNA collection devices in the market. But shortly after the COVID-19 crisis began, Gentueri pivoted sharply. Recognizing the threat early on, the company extended its production to include COVID-19 test kits.

The new facility is four times the size of its previous location and will allow the company to increase capacity, expedite orders, add new innovative products, and serve customers with quality products.

Randy Nagy, founder of Gentueri commented, “Obtaining FDA Registration of our new larger facility represents an important step in our expansion plans as we significantly increase capacity and meet the requirements of new medical device markets. We are also proud to continue our fight against COVID-19 with our new product listings for Viral Transport Media Kits and our PBS Response Kit.”

In compliance with the Unique Device Identification (UDI) requirements, the company is now approved by the FDA to manufacture and distribute both its Viral Transport Media Kits (VTM) and PBS Response Kits. The kits are helping to facilitate COVID-19 testing for residents across the state of Wisconsin as well as neighboring states.

Gentueri plans to use their new, larger medical device facility to expand its ability to fight COVID-19, enter new markets and design innovative biospecimen collection devices that collect samples easily and preserve them at room temperature, enabling convenient integration into downstream automated analytical systems.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The relationship between pharmaceutical companies and CDMOs is fundamentally collaborative, fostering an environment of innovation. By partnering with a CDMO, pharmaceutical firms can access a wide array of technologies and expertise that might otherwise be beyond their reach.
Serum Detect is developing diagnostic tests, using standard liquid biopsy samples, that complement and enhance existing screening techniques for early detection of cancer.
The company announced the launch of validated antibodies for rare cell and circulating tumor cell (CTC) enumeration. Validated for use with Bio-Rad’s Celselect Slides Enumeration Stain Kits, the antibodies are specific to CTC surface markers to enable the sensitive and specific identification of target cell populations, enhancing the study of tumor heterogeneity and disease progression at various stages.
Proteintech advises the new building houses research and development, production, logistics and administration in an area more than three times larger than its previous space.
In September 2023, Seegene and Springer Nature opened applications to scientists and experts across the global community to conduct research for the 15 designated projects to develop Seegene's syndromic qPCR diagnostics assay reagents for the Open Innovation Program.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version